Minerva Neurosciences, Inc. Notes Payable, Noncurrent
Minerva Neurosciences, Inc. (NERV) had Notes Payable, Noncurrent of $1.33 million as of 2017-06-30, per its 10-Q filed 2017-08-03.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt, Excluding Current Maturities
us-gaap:LongTermNotesPayable · last filed 2018-03-12
- 2017-06-30: Notes Payable, Noncurrent $1.33M.
- 2017-03-31: Notes Payable, Noncurrent $2.60M.
- 2016-12-31: Notes Payable, Noncurrent $3.84M.
- 2016-09-30: Notes Payable, Noncurrent $5.05M.
| Period end | Notes Payable, Noncurrent |
|---|---|
| 2017-06-30 | $1.33M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $2.60M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $3.84M 10-K · filed 2018-03-12 |
| 2016-09-30 | $5.05M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $6.23M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $7.38M 10-Q · filed 2016-05-03 |
| 2015-12-31 | $8.50M 10-K · filed 2017-03-13 |
| 2015-09-30 | $9.61M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $8.70M 10-Q · filed 2015-08-05 |
| 2015-03-31 | $9.55M 10-Q · filed 2015-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |